Related Experiment Video
Updated: Aug 19, 2025

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Interleukin-1β triggers matrix metalloprotease-3 expression through p65/RelA activation in melanoma cells
Junichi Nunomura1, Rei Nakano1,2,3, Atsuto Naruke1
1Laboratories of Veterinary Radiotherapy, Nihon University College of Bioresource Sciences, Fujisawa, Kanagawa, Japan.
Abstract:
Melanoma shows highly aggressive behavior (i.e., local invasion and metastasis). Matrix metalloprotease-3 (MMP-3), a zinc-dependent endopeptidase, degrades several extracellular substrates and contributes to local invasion by creating a microenvironment suitable for tumor development. Here, we report that interleukin-1β (IL-1β) triggers the MMP-3 expression in canine melanoma cells. The activity of MMP-3 in the culture supernatant was increased in IL-1β-treated melanoma cells. IL-1β time- and dose-dependently provoked the mRNA expression of MMP-3. IL-1β induced the migration of melanoma cells; however, this migration was attenuated by UK356618, an MMP-3 inhibitor. When the cells were treated with the nuclear factor-κB (NF-κB) inhibitor TPCA-1, the inhibition of MMP-3 expression was observed. In IL-1β-treated cells, the phosphorylation both of p65/RelA and p105 was detected, indicating NF-κB pathway activation. In p65/RelA-depleted melanoma cells, IL-1β-mediated mRNA expression of MMP-3 was inhibited, whereas this reduction was not observed in p105-depleted cells. These findings suggest that MMP-3 expression in melanoma cells is regulated through IL-1β-mediated p65/RelA activation, which is involved in melanoma cell migration.
Insights
Interleukin-1β (IL-1β) increases matrix metalloprotease-3 (MMP-3) in canine melanoma cells, promoting tumor cell migration. This process involves the nuclear factor-kappa B (NF-κB) pathway, specifically p65/RelA activation.
Area of Science:
- Oncology
- Molecular Biology
- Veterinary Medicine
Background:
- Melanoma is an aggressive skin cancer characterized by local invasion and metastasis.
- Matrix metalloprotease-3 (MMP-3) degrades extracellular matrix components, facilitating tumor invasion and development.
- Interleukin-1β (IL-1β) is a pro-inflammatory cytokine implicated in various cancers.
Purpose of the Study:
- To investigate the role of IL-1β in regulating MMP-3 expression and canine melanoma cell migration.
- To elucidate the signaling pathway involved in IL-1β-induced MMP-3 expression.
Main Methods:
- Canine melanoma cells were treated with IL-1β.
- MMP-3 expression and activity were measured using quantitative real-time PCR and enzyme activity assays.
- Cell migration was assessed using a wound healing assay.
- Inhibitors of MMP-3 (UK356618) and NF-κB (TPCA-1) were used.
- Western blotting was performed to detect protein phosphorylation.
- Gene silencing of NF-κB subunits (p65/RelA and p105) was conducted.
Main Results:
- IL-1β treatment significantly increased MMP-3 mRNA expression and enzyme activity in canine melanoma cells.
- IL-1β induced melanoma cell migration, which was reduced by MMP-3 inhibition.
- NF-κB pathway activation, indicated by p65/RelA and p105 phosphorylation, was observed upon IL-1β treatment.
- Inhibition of NF-κB signaling by TPCA-1 suppressed IL-1β-induced MMP-3 expression.
- Depletion of p65/RelA, but not p105, abolished IL-1β-mediated MMP-3 mRNA upregulation.
Conclusions:
- IL-1β stimulates MMP-3 expression and promotes migration in canine melanoma cells.
- The IL-1β-induced MMP-3 expression is mediated through the activation of the NF-κB pathway, specifically involving the p65/RelA subunit.
- Targeting the IL-1β/NF-κB/MMP-3 axis may represent a therapeutic strategy for canine melanoma.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Role of Matrix Metalloproteases in Degradation of ECM
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway

